Garth Powis
Affiliations: | University of Arizona, Tucson, AZ |
Area:
Cell Biology, Biochemistry, Molecular BiologyGoogle:
"Garth Powis"Mean distance: (not calculated yet)
Children
Sign in to add traineeBryan E. Husbeck | grad student | 2002 | University of Arizona |
Larisa Nonn | grad student | 2003 | University of Arizona |
Warner B. Bair | grad student | 2006 | University of Arizona |
Amy E. Coon | grad student | 2006 | University of Arizona |
Kara E. Rogers | grad student | 2006 | University of Arizona |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jeung HC, Delaney R, Aleshin A, et al. (2021) PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer. Experimental Cell Research. 112930 |
Maruggi M, Layng FIAL, Lemos R, et al. (2019) Absence of HIF1A leads to glycogen accumulation and an inflammatory response that enables pancreatic tumor growth. Cancer Research |
Indarte M, Puentes R, Maruggi M, et al. (2019) An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors. Cancer Research |
Campos AD, James B, Jong PD, et al. (2018) Abstract 2428: Redox regulation of β-catenin in colorectal cancer Cancer Research. 78: 2428-2428 |
Grandjean G, De Jong PR, James BP, et al. (2016) Definition of a novel feed-forward mechanism for glycolysis-HIF1α signaling in hypoxic tumors highlights adolase A as a therapeutic target. Cancer Research |
Lee MS, Helms TL, Feng N, et al. (2016) Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models. Oncotarget |
Nam S, Chang HR, Jung HR, et al. (2015) A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer. Cancer Letters. 356: 880-90 |
Koh MY, Nguyen V, Lemos R, et al. (2015) Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma. Cancer Research. 75: 316-29 |
Kirkpatrick DL, Indarte M, Scott M, et al. (2015) Abstract 2583: Refinement of inhibitors of the KRAS-signaling naocluster protein, CNKSR1, that block oncogenic KRAS signaling and growth Cancer Research. 75: 2583-2583 |
Nam S, Chang HR, Kim KT, et al. (2014) PATHOME: an algorithm for accurately detecting differentially expressed subpathways. Oncogene. 33: 4941-51 |